Ignite Creation Date:
2025-12-25 @ 12:11 AM
Ignite Modification Date:
2026-01-01 @ 12:29 PM
Study NCT ID:
NCT00315458
Status:
TERMINATED
Last Update Posted:
2012-09-03
First Post:
2006-04-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Buprenorphine Transdermal Patch in Subjects With Osteoarthritis Pain Requiring Opioids. Includes a 52-Week Safety Extension.
Sponsor:
Purdue Pharma LP
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-12
Start Date Type:
None
Primary Completion Date:
2005-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-03
Completion Date Type:
ACTUAL
First Submit Date:
2006-04-17
First Submit QC Date:
None
Study First Post Date:
2006-04-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-07-28
Results First Submit QC Date:
None
Results First Post Date:
2010-09-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-08-27
Last Update Post Date:
2012-09-03
Last Update Post Date Type:
ESTIMATED